A cardiometabolic risk phenotype index integrating insulin resistance, systemic inflammation, and psychological burden for mortality risk stratification in metabolic dysfunction-associated steatotic liver disease: an exploratory longitudinal analysis of a nationally representative cohort.
Lipids in health and disease · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansFemaleInsulin ResistanceMaleMiddle AgedInflammationLongitudinal StudiesAdultFatty LiverCardiovascular DiseasesCardiometabolic Risk FactorsNutrition SurveysPhenotypeMetabolic SyndromeRisk FactorsAgedNon-alcoholic Fatty Liver DiseaseProportional Hazards ModelsCardiometabolic riskCardiovascular mortalityInsulin resistanceMASLDNHANESPsychological burdenSystemic inflammation
Come citare questo studio
Yan Chen, Kailing Xie, Ningkun Xiao, Haonan Ju, Qingzhi Zhou, Xin Zhao. (2026). A cardiometabolic risk phenotype index integrating insulin resistance, systemic inflammation, and psychological burden for mortality risk stratification in metabolic dysfunction-associated steatotic liver disease: an exploratory longitudinal analysis of a nationally representative cohort.. Lipids in health and disease. DOI: 10.1186/s12944-026-03048-4
Consulta la pubblicazione originale ↗